Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

42.30 +1.64 (+4.03%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 865,763
Open 40.91
Bid (Size) 42.30 (500)
Ask (Size) 44.00 (200)
Prev. Close 40.66
Today's Range 40.59 - 43.06
52wk Range 23.23 - 43.06
Shares Outstanding 32,250,236
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
COLL Q3 Deep Dive: Jornay PM Momentum and Pain Portfolio Drive Upgraded Outlook
Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 31.4% year on year to $209.4 million. The company’s full-year revenue... 
Via StockStory
Why Are Collegium Pharmaceutical (COLL) Shares Soaring Today
Shares of pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) jumped 11.6% in the morning session after the company reported strong third-quarter 2025 financial results, beating analyst... 
Via StockStory
Topics Economy Government World Trade

Performance

YTD
+47.7%
+47.7%
1 Month
+27.4%
+27.4%
3 Month
+17.0%
+17.0%
6 Month
+43.1%
+43.1%
1 Year
+31.5%
+31.5%

More News

Read More
Collegium Pharmaceutical Inc (NASDAQ:COLL) Beats Q3 2025 Estimates and Raises Full-Year Guidance
Via Chartmill
Collegium Pharmaceutical (NASDAQ:COLL) Delivers Impressive Q3, Stock Jumps 12.1%
Via StockStory
Earnings Scheduled For November 6, 2025
Via Benzinga
Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Earnings To Watch: Collegium Pharmaceutical (COLL) Reports Q3 Results Tomorrow
Via StockStory
3 Stocks Under $50 That Fall Short
Via StockStory
Topics Artificial Intelligence
Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Pharmaceutical (COLL): Buy, Sell, or Hold Post Q2 Earnings?
Via StockStory
Topics Stocks Supply Chain
Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
UnitedHealth, Brookdale, Collegium Pharmaceutical, QuidelOrtho, and Biogen Shares Are Falling, What You Need To Know
Via StockStory
Topics Economy Government World Trade
1 Russell 2000 Stock to Research Further and 2 We Avoid
Via StockStory
Branded Pharmaceuticals Stocks Q2 Highlights: Collegium Pharmaceutical (NASDAQ:COLL)
Via StockStory
Topics Artificial Intelligence Intellectual Property
1 Safe-and-Steady Stock to Keep an Eye On and 2 Facing Headwinds
Via StockStory
Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
1 Stock Under $50 Worth Investigating and 2 We Ignore
Via StockStory
3 Profitable Stocks We Think Twice About
Via StockStory
COLL Q2 Deep Dive: Jornay Expansion Drives Revenue Guidance Increase, Margins Face Investment Pressure
Via StockStory
Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q2 Expectations, Stock Jumps 10.2%
Via StockStory
Collegium (COLL) Q2 Revenue Jumps 29%
Via The Motley Fool
Topics Intellectual Property
Collegium Pharmaceutical Inc (NASDAQ:COLL) Reports Record Q2 2025 Earnings and Raises Full-Year Guidance
Via Chartmill

Frequently Asked Questions

Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?
Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.
What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?
Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?
The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market
What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?
The current price of Collegium Pharmaceutical, Inc. - Common Stock is 42.30
When was Collegium Pharmaceutical, Inc. - Common Stock last traded?
The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 11/07/25 04:00 PM ET
What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?
The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 1.36B
How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?
Collegium Pharmaceutical, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.